The alteration of miRNAs of both oncomirs and oncosuppressors as well as the expression of markers associated with the epithelial–mesenchymal transition (EMT) under the action of RNase A were studied in blood, metastatic foci and adjacent lung tissue (modeling tumor environment) in the context of inhibiting tumor progression in vivo. The gene discussed is RNASE1; the disease is neoplasm.